NeuroVive’s Nomination Committee amends its proposal to the 2020 Annual General Meeting
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) today announced that the Company's Nomination Committee in its proposal to the Annual General Meeting May 20, 2020, added a proposal regarding an ad ...